Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» FDA approves Amgen immunotherapy drug Blincyto for rare form of leukemia
FDA approves Amgen immunotherapy drug Blincyto for rare form of leukemia
FDA approves Amgen immunotherapy drug Blincyto for rare form of leukemia
Submitted by
admin
on December 3, 2014 - 9:18pm
Source:
Yahoo/AP
News Tags:
FDA
Amgen
Blincyto
B-cell acute lymphoblastic leukemia
Headline:
FDA approves Amgen immunotherapy drug Blincyto for rare form of leukemia
Do Not Allow Advertisers to Use My Personal information
